JBS N.V. Class A Common Shares vs Kimberly Clark Corp — how do they compare? JBS N.V. Class A Common Shares trades at $12.98 (market cap $13.96B), while Kimberly Clark Corp trades at $104.25 (market cap $33.06B). The key difference: Kimberly Clark Corp is far larger — about 2.4× JBS N.V. Class A Common Shares's market cap, and JBS N.V. Class A Common Shares pays the higher dividend (10.31%). Which is the better fit depends on your goals — on Pluang, investors hold JBS N.V. Class A Common Shares for 0 Days and Kimberly Clark Corp for 94 Days on average.
| JBS | KMB | |
|---|---|---|
Market Cap | $13.96B | $33.06B |
Volume | 5,326,589 | 6,233,100 |
Sector | Consumer Staples | Consumer Staples |
52-Week High | $18.42 | $121.44 |
52-Week Low | $10.86 | $93.05 |
Typical Hold Time | 0 Days | 94 Days |
Enterprise Value | $34.93B | $38.62B |
Dividend Yield | 10.31% | 5.15% |
Signals from Pluang's Aura AI — not financial advice
JBS trades at $12.93, up 0.54% today, with a neutral technical signal and strong analyst buy consensus. The stock shows attractive valuation with a P/E of 12.08 and P/S of 0.47, though recent quarterly EPS misses and a declining profit margin to 1.22% in 2026 highlight earnings pressure. Recent news includes a proposal to acquire full control of Pilgrim's Pride and a joint venture in Southeast Asia, indicating strategic expansion.
The outlook is mixed: analyst targets suggest ~40% upside to $18.17, but risks include execution on acquisitions, margin compression, and volatile beef markets. Cash flow turned positive in 2026 projections, supporting growth initiatives, yet debt levels and competitive pressures warrant caution for investors seeking stability.
Kimberly-Clark (KMB) trades at $98.29, down 0.49% on the day, with a bearish technical signal despite recent earnings beats. The stock shows strong profitability with 11.79% net margins and 129.43% ROE, though revenue declined to $16.45B in 2025. Analysts maintain a $117.25 consensus target with 32% buy ratings, while the pending Kenvue acquisition and executive transitions create both opportunity and uncertainty.
KMB offers a compelling 5.16% dividend yield with 54 consecutive years of increases, but cash flow concerns and acquisition integration risks warrant caution. The stock trades at reasonable valuations (P/E 19.65) with potential 19% upside to analyst targets, making it attractive for income investors despite near-term headwinds from the Kenvue deal execution.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
JBS N.V. is a protein-processing company producing beef, pork, poultry, lamb, fish, and plant-based products, headquartered in São Paulo and Amsterdam. It operates more than 250 production facilities across over 16 countries under brands including Friboi, Seara, Swift, and Pilgrim's, and is the majority shareholder of Pilgrim's Pride Corporation.
Read more on JBS →With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →